Skip to main content
. 2020 Jun 8;123(5):785–792. doi: 10.1038/s41416-020-0925-4

Fig. 2. ER pathway activity in proliferative endometrium, premalignant (hyperplastic) endometrium and endometrial cancer in the EC Affymetrix dataset and Nijmegen clinical cohort.

Fig. 2

a ER pathway activity scores according to endometrial cancer grade and histology in the EC Affymetrix dataset (datasets GSE56026 and GSE2109). b ER pathway activity scores in proliferative endometrium (benign), endometrial hyperplasia (premalignant) and various types of endometrial cancer in the clinical cohort. EEC endometrioid-type endometrial cancer, USC uterine serous cancer. Proliferative: proliferative endometrium; hyperplasia: endometrial hyperplasia. Dots represent samples from individual patients. ***P ≤ 0.001; **P ≤ 0.01; *P < 0.05.